EU-OPENSCREEN 2022: About EU-OPENSCREEN ERIC
EU-OPENSCREEN is a not-for-profit European Research Infrastructure Consortium (ERIC) for chemical biology and early drug discovery. EU-OPENSCREEN operates an open-access database and a unique, common compound collection. EU-OPENSCREEN has over 30 affiliated high-throughput screening and chemistry facilities at partner sites in 9 European countries. EU-OPENSCREEN aims to support global scientific and economic competitiveness of Europe through delivering public health benefits. Our mission is to be the leading European research infrastructure for chemical biology – developing small molecule modulators. EU-OPENSCREEN provides open access to the most advanced screening and medicinal chemistry technologies and expertise. EU-OPENSCREEN will become the premier European technology and expertise platform for chemical biology. Central to our vision is the ambition to help improve human health, and the quality of life of an ageing population.
This company is:
Verified
EU-OPENSCREEN 2022: FAQs
FAQs | What happens to my intellectual property? | Which costs are involved? | Please contact us | News
Verified
EU-OPENSCREEN 2022: Training
Training Courses | Upcoming Training Courses | Webinar: How blending chemistry and biology can enable systems pharmacology | Previous Training Courses | High throughput and high content fluorescent imaging tools and technologies | Webinar: Demystifying Data Science for Image-Based Phenotypic Screening | Webinar: Mitochondria as a druggable target focusing on the history of mitochondriotropic antioxidants | Webinar: Antimalarial Drug Discovery | Webinar: Open-Source Chemical Probes for Understanding Cellular Phenotypes | Addressing drug discovery challenges from the natural products space | Autumn training school 2022 - November 14-18, 2022 (Virtual event) | Webinar: The development of functional precision medicine tools for ovarian cancer | Prague Summer School on Drug Discovery | Webinar: “HTS-driven drug discovery: The screening deck quality with proper hit triage is everything” | Webinar: Design, synthesis and screening of fragment libraries for protein and RNA targets | Webinar: Interface between Structural Biology and Medicinal Chemistry: An NMR case study of targeting SARS-CoV-2 | Webinar on "Tools towards the discovery of metastasis modulators" | On site training at IMG in Prague: Compound Logistics Course | Webinar on cellular phenotyping of human stem cells | Webinar "The Chemical Biology Consortium Sweden (CBCS) -Project examples and lessons learned from more than 10 years of operations" Feb 22, 2022 10:00 AM CET | High Throughput Screening at EU-OPENSCREEN SPARK Webinar with Dr. Edgar Specker (former EU-OPENSCREEN Interim Lab Automation Manager) Date: February 2, 2022 | 4-5 pm (CET) | Online Webinar | ONLINE - Autumn training school 2021 - November 15-19th, 2021 | Webinar: Introduction to chemosensitive profiling - November 26th, 2020,15:00-16:00 CET | Speaker: Dr Sheraz Gul, Head of Assay Development & Screening, Fraunhofer IME ScreeningPort, Hamburg | Webinar "Tool compound/Probe evaluation and selection" - September 23rd, 2020 | Webinar “DNA-encoded libraries to identify novel chemical matter for undruggable targets” | Webinar "Introduction to High-Throughput Screening" - Thursday, April 2, 2020, 15:00-16:15 CET | Compound Logistics Course | Place: Institute of Molecular Genetics (IMG) CZ-OPENSCREEN Prague | Date: November 28, 2019 | Registration deadline: October 31st, 2019 | Webinar: "Quality in Screening" | Lecturers: Matthew Hall (NIH/NCATS) and Wolfgang Fecke (EU-OPENSCREEN) | Online: November 19 from 15:00 to 16:00 CET | News
Verified
EU-OPENSCREEN 2022: Screening
Screening | This process includes the following services: | Work with us: Submit your screening request! | Download | News | Screening partner sites | CZECH REPUBLIC | Palacký University Olomouc - Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine (IMTM) | Institute of Molecular Genetics AS CR, v. v. i. (IMG) | DENMARK | Biotech Research and Innovation Centre (BRIC) | FINLAND | University of Helsinki, Faculty of Pharmacy - Division of Pharmaceutical Biosciences | Institute for Molecular Medicine Finland (FIMM) - High Throughput Biomedicine (HTB) unit | Germany | Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP)/MDC Berlin - Chemical Biology – Screening Unit | Helmholtz-Zentrum für Infektionsforschung GmbH (HZI) - Department of Chemical Biology (CBIO) | Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) – Drug Discovery - Screening Port | Dr. Philip Gribbon | Norway | University of Bergen, Department of Biomedicine - Faculty of Medicine and Dentistry | University of Oslo - Faculty of Medicine / Biotechnology Centre of Oslo (BiO) and Centre for Molecular Medicine (NCMM) | Arctic University of Norway, Faculty of Biosciences, Economics and Fisheries | SINTEF Materials and Chemistry | POLAND | Polish Academy of Sciences - Institute of Medical Biology, Screening laboratory for anti-viral and anti-bacterial compounds (IMB PAS) | Polish Academy of Science - Institute of Bioorganic Chemistry (IBCH) | PORTUGAL | Institute of Molecular and Cell Biology - Innovation and Health Research Institute of Porto University (i3S-LA) | | University of Coimbra - Centre for Neuroscience and Cell Biology (CNC-UC) | SPAIN | FUNDACION MEDINA - Screening and target validation, Microbiology and Chemistry | Prince Felipe Research Center (CIPF) - Advanced Therapies Program, Screening Platform | University of Santiago de Compostela - BioFarma Research Group | SWEDEN | Karolinska Institutet - Department Medical Biochemistry and Biophysics (CBCS-KI) | Umeå University - Chemical Biology Centre (CBCS-UmU)
View all products
Keywords
Industries
Where is EU-OPENSCREEN located?
The company EU-OPENSCREEN is located in Berlin, Germany. It's worth noting that the company may has more corporate locations
How many employees does EU-OPENSCREEN approximately have?
As of the latest available information EU-OPENSCREEN has around 11-50 employees worldwide.
When was EU-OPENSCREEN founded?
EU-OPENSCREEN was founded in 2018
In which industries does EU-OPENSCREEN mainly work?
The company EU-OPENSCREEN has it's main focus in the industries of Data and Analytics
OpenRiskNet
Switzerland
2016
European Lead Factory
Netherlands
51-100 Employees
2013
European Confederation of Pharmaceutical Entrepreneurs
Belgium
1-10 Employees
2008
CERIC-ERIC
Italy
11-50 Employees
2014
ECRIN (European Clinical Research Infrastructure Network)
France
11-50 Employees
2013
Brussels South Charleroi BioPark
Belgium
1-10 Employees
1999
EUROPRACTICE
Belgium
51-100 Employees
1989
InSCREENeX
Germany
1-10 Employees
2009
Topics which have been searched by others and may be interesting for you: